About Quiet Therapeutics

About company

Quiet Therapeutics is an emerging biotech company founded in 2010 developing a proprietary nanoparticle-based delivery system (gagomers) focused on oncology and inflammation. Based on the targeting capability of our innovative technology, the company is well positioned to expand the drug target repertoire in cancer and inflammation. The Gagomer delivery approach enables us to target cell components that are not manageable by other therapeutic agents like small molecules or antibodies.